CenTrial Logo

What are Best Transportation Options for Stroke Patients in Non-Urban Areas?

by


Clinical trial finds that transporting stroke patients to local center is as effective as thrombectomy-capable centers

Thrombectomy is a procedure that removes blood clots from large vessels in the brain, and it is often necessary to improve outcomes in stroke patients. However, not all hospitals are equipped to perform this procedure, especially in non-urban areas.

Clinical Trial

A clinical trial explored the best ways to transport stroke patients in areas without easy access to specialized treatment centers. The trial, which was conducted in Catalonia, Spain, aimed at determining whether directly transporting patients to a specialized thrombectomy-capable center or to a local stroke center was more beneficial.

The trial included 1,401 patients who were suspected of having a large-vessel occlusion stroke, meaning a blood clot was blocking a major blood vessel in their brain. All patients were attended to by emergency medical services and were transported to either the closest local stroke center or a thrombectomy-capable center.

Results

The trial found that there was no significant difference in neurological outcomes between patients who were transported directly to the specialized center and those who were taken to a local stroke center first. The main thing the researchers looked at was how disabled people were 90 days after they had a stroke. They used a special scale to measure this, which went from 0 (no problems) to 6 (dead). They also looked at other things like how many people got certain types of treatment and how many people died within 90 days.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me

Interestingly, the trial did find that patients who were transported directly to the specialized center were less likely to receive intravenous tissue plasminogen activator but more likely to receive thrombectomy. Intravenous tissue plasminogen activator is a medication used to dissolve blood clots, and it is often administered to stroke patients who are not eligible for thrombectomy or who need additional treatment. However, the medication must be given within a certain timeframe after the onset of symptoms, and delays in transportation may make it less effective.

The clinical trial was conducted in non-urban areas in Catalonia, Spain, where access to specialized treatment centers may be limited. The results suggest that transporting stroke patients to the closest local stroke center may be just as effective as directly transporting them to a thrombectomy-capable center in these settings.

Conclusion

This clinical trial found that there was no significant difference in neurological outcomes between stroke patients who were transported directly to a thrombectomy-capable center and those who were taken to a local stroke center first. However, patients who were transported directly to the specialized center were less likely to receive intravenous tissue plasminogen activator but more likely to receive thrombectomy. It is important to conduct further research in other regions to determine the best transportation strategies for stroke patients.

__________

JAMA Network, May-05-22
ClinicalTrials.gov, NCT02795962




Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Without participants there can be no clinical trials.
Without clinical trials there will be no new treatments.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.